3 studies found for:    21561347 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer
Condition: Stage IV Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Drug: nab-paclitaxel;   Drug: FOLFIRINOX;   Genetic: Immunohistochemistry (IHC) Analysis;   Drug: Metformin;   Drug: mFOLFIRI
2 Recruiting Xeloxiri as First-line Treatment in Patients With Advanced Unresectable Pancreatic Adenocarcinoma
Condition: Pancreatic Adenocarcinoma
Interventions: Drug: Capecitabine;   Drug: Oxaliplatin;   Drug: Irinotecan
3 Unknown  Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: fluorouracil;   Drug: gemcitabine hydrochloride;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium;   Drug: oxaliplatin

Indicates status has not been verified in more than two years